Skip to main content
. 2020 Jan 24;8(4):418–424. doi: 10.1177/2050640620902956

Figure 1.

Figure 1.

Clinical outcomes of Crohn’s disease patients treated with ustekinumab. Clinical response was defined as a drop reduction of at least 1 severity category by the Harvey–Bradshaw index (HBI). Patients with HBI < 5 were considered to be in clinical remission.